Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Monique Spillman

Concepts (262)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
17
2023
450
1.880
 Why?
Endometrial Neoplasms
5
2015
137
0.860
 Why?
Gynecology
5
2020
48
0.830
 Why?
Genital Neoplasms, Female
2
2020
41
0.770
 Why?
Gene Expression Regulation, Neoplastic
10
2019
833
0.750
 Why?
Cystadenocarcinoma, Serous
4
2021
71
0.720
 Why?
Infection Control
1
2020
47
0.680
 Why?
Ethics, Medical
1
2020
46
0.670
 Why?
Communication
1
2020
250
0.600
 Why?
Conflict of Interest
3
2016
25
0.590
 Why?
Uterus
1
2018
85
0.580
 Why?
Medical Oncology
3
2020
99
0.570
 Why?
Robotics
2
2014
41
0.560
 Why?
Pneumonia, Viral
1
2020
169
0.550
 Why?
Peptides
3
2015
221
0.550
 Why?
Coronavirus Infections
1
2020
178
0.540
 Why?
Receptors, Estrogen
5
2017
132
0.540
 Why?
Medroxyprogesterone Acetate
1
2015
6
0.510
 Why?
Fallopian Tube Neoplasms
2
2013
14
0.510
 Why?
Antineoplastic Agents, Hormonal
1
2015
49
0.490
 Why?
Pandemics
1
2020
563
0.490
 Why?
Glycoproteins
1
2015
116
0.490
 Why?
Gynecologic Surgical Procedures
2
2014
29
0.480
 Why?
Neoplastic Stem Cells
1
2015
98
0.470
 Why?
Antigens, CD
1
2015
222
0.460
 Why?
Adenocarcinoma
2
2015
397
0.460
 Why?
Female
34
2023
27086
0.420
 Why?
Salpingectomy
1
2013
6
0.420
 Why?
MicroRNAs
4
2021
344
0.420
 Why?
Pelvic Neoplasms
1
2013
14
0.420
 Why?
General Surgery
1
2014
108
0.420
 Why?
Peritoneal Neoplasms
2
2011
63
0.410
 Why?
Estrogens
2
2012
226
0.400
 Why?
Clinical Trials as Topic
2
2007
486
0.380
 Why?
Medicare Part B
1
2011
5
0.380
 Why?
Professional Corporations
1
2011
1
0.380
 Why?
Marketing of Health Services
1
2011
7
0.380
 Why?
Reimbursement Mechanisms
1
2011
22
0.380
 Why?
Physicians
2
2016
232
0.370
 Why?
Social Responsibility
1
2011
25
0.370
 Why?
Receptors, Progesterone
4
2015
64
0.370
 Why?
Cell Line, Tumor
11
2016
1398
0.370
 Why?
Trust
1
2011
61
0.360
 Why?
Humans
42
2023
50509
0.360
 Why?
Carcinoma, Large Cell
1
2010
15
0.360
 Why?
Carcinoma, Neuroendocrine
1
2010
23
0.350
 Why?
Interprofessional Relations
1
2011
83
0.350
 Why?
Health Care Reform
1
2010
22
0.350
 Why?
Physician-Patient Relations
1
2011
142
0.340
 Why?
Breast Neoplasms
4
2012
1201
0.320
 Why?
Uterine Neoplasms
2
2019
60
0.300
 Why?
Transplantation, Heterologous
2
2012
75
0.290
 Why?
Uterine Cervical Neoplasms
1
2010
276
0.290
 Why?
Physician's Role
2
2011
48
0.280
 Why?
MAP Kinase Kinase 4
1
2007
29
0.280
 Why?
Apoptosis
5
2016
1097
0.270
 Why?
Genes, Tumor Suppressor
1
2007
73
0.270
 Why?
Advance Directives
1
2007
29
0.270
 Why?
Patient Dropouts
1
2007
52
0.270
 Why?
Gene Expression Regulation, Enzymologic
1
2007
179
0.250
 Why?
Receptors, Transforming Growth Factor beta
1
2005
25
0.240
 Why?
Claudin-4
2
2016
7
0.240
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1000
0.230
 Why?
Ovary
1
2004
103
0.230
 Why?
Hysterectomy
2
2014
88
0.230
 Why?
Epithelial Cells
1
2004
207
0.210
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2017
572
0.210
 Why?
Aged
11
2021
9743
0.200
 Why?
Neoplasm Staging
4
2021
746
0.200
 Why?
Middle Aged
12
2021
12614
0.200
 Why?
Gene Expression Profiling
3
2019
1025
0.190
 Why?
Cisplatin
2
2015
286
0.190
 Why?
Immunohistochemistry
6
2017
957
0.180
 Why?
Cell Movement
3
2016
247
0.180
 Why?
Resource Allocation
1
2020
16
0.170
 Why?
Standard of Care
1
2020
18
0.170
 Why?
Disclosure
2
2016
39
0.170
 Why?
Loss of Heterozygosity
2
2013
75
0.170
 Why?
Lymphatic Metastasis
2
2010
222
0.170
 Why?
Early Detection of Cancer
1
2021
163
0.160
 Why?
Leiomyosarcoma
1
2019
20
0.160
 Why?
Leiomyoma
1
2019
24
0.160
 Why?
Neoplasm Invasiveness
3
2015
269
0.160
 Why?
Xenograft Model Antitumor Assays
4
2012
212
0.160
 Why?
RNA-Binding Proteins
2
2019
118
0.150
 Why?
Informed Consent
3
2004
97
0.150
 Why?
Death
1
2018
21
0.150
 Why?
Living Donors
1
2018
24
0.150
 Why?
Critical Care
1
2020
214
0.150
 Why?
Neoplasms, Glandular and Epithelial
2
2015
41
0.150
 Why?
Palliative Care
1
2020
190
0.150
 Why?
Carcinosarcoma
1
2017
18
0.150
 Why?
Microfilament Proteins
1
2017
42
0.140
 Why?
Sequence Analysis, RNA
1
2017
89
0.140
 Why?
United States
4
2016
4958
0.130
 Why?
Adult
7
2021
13583
0.130
 Why?
Mice, Nude
3
2012
248
0.130
 Why?
Industry
1
2016
17
0.130
 Why?
Carrier Proteins
1
2017
298
0.130
 Why?
Keratin-5
1
2015
1
0.130
 Why?
Receptors, Androgen
1
2015
45
0.130
 Why?
Cell Count
1
2015
150
0.120
 Why?
Cell Proliferation
4
2015
985
0.120
 Why?
Prognosis
4
2017
1978
0.120
 Why?
Neoplasm Seeding
1
2014
4
0.120
 Why?
Genetic Privacy
2
2004
3
0.120
 Why?
Alanine
1
2014
43
0.110
 Why?
Triazines
1
2014
24
0.110
 Why?
Endometrium
1
2014
40
0.110
 Why?
Genes, BRCA2
1
2013
12
0.110
 Why?
Mice
6
2016
5687
0.110
 Why?
Genes, BRCA1
1
2013
19
0.110
 Why?
Insurance, Health, Reimbursement
1
2013
24
0.110
 Why?
Health Care Costs
2
2013
167
0.100
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
7
0.100
 Why?
DNA Methylation
3
2023
550
0.100
 Why?
Risk Reduction Behavior
1
2013
58
0.100
 Why?
Carcinoma, Lobular
1
2012
33
0.100
 Why?
DNA-Binding Proteins
2
2013
418
0.100
 Why?
Paclitaxel
1
2012
84
0.100
 Why?
Lymph Nodes
1
2014
257
0.100
 Why?
Antibodies, Neoplasm
1
2012
28
0.100
 Why?
Coercion
1
2011
6
0.100
 Why?
Judicial Role
1
2011
6
0.100
 Why?
Medicare Payment Advisory Commission
1
2011
2
0.100
 Why?
Personal Autonomy
1
2011
15
0.100
 Why?
Women
1
2011
29
0.100
 Why?
Prejudice
1
2011
39
0.090
 Why?
Politics
1
2011
27
0.090
 Why?
Homeodomain Proteins
1
2012
79
0.090
 Why?
Quality of Health Care
1
2013
184
0.090
 Why?
Violence
1
2011
60
0.090
 Why?
M Phase Cell Cycle Checkpoints
1
2011
4
0.090
 Why?
Taxoids
1
2011
37
0.090
 Why?
RNA, Messenger
2
2012
1089
0.090
 Why?
Selective Estrogen Receptor Modulators
1
2010
24
0.090
 Why?
Organ Specificity
1
2010
109
0.090
 Why?
Immunoenzyme Techniques
1
2010
137
0.090
 Why?
Obstetrics
1
2011
84
0.090
 Why?
Models, Statistical
1
2011
226
0.090
 Why?
Cesarean Section
1
2011
157
0.090
 Why?
Neoplasm Recurrence, Local
1
2014
629
0.090
 Why?
Alcohol Drinking
1
2011
227
0.080
 Why?
Societies, Medical
1
2010
187
0.080
 Why?
Blotting, Western
1
2010
578
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
405
0.080
 Why?
Transfection
2
2012
356
0.080
 Why?
Phosphorylation
2
2008
525
0.080
 Why?
Animals
6
2016
13124
0.080
 Why?
Aging
1
2013
694
0.070
 Why?
Aged, 80 and over
4
2021
3228
0.070
 Why?
Alleles
2
2006
256
0.070
 Why?
Antineoplastic Agents
1
2015
1172
0.070
 Why?
Case-Control Studies
2
2014
1156
0.070
 Why?
Chimera
1
2007
10
0.070
 Why?
CpG Islands
1
2007
108
0.070
 Why?
MAP Kinase Signaling System
1
2007
117
0.070
 Why?
Genomic Imprinting
1
2006
8
0.070
 Why?
Insulin-Like Growth Factor II
1
2006
17
0.070
 Why?
RNA, Untranslated
1
2006
13
0.060
 Why?
Health Services Accessibility
1
2010
424
0.060
 Why?
Base Sequence
1
2007
639
0.060
 Why?
Repetitive Sequences, Amino Acid
1
2005
1
0.060
 Why?
Molecular Sequence Data
1
2007
778
0.060
 Why?
Models, Biological
2
2008
716
0.060
 Why?
North Carolina
1
2005
52
0.060
 Why?
Databases, Nucleic Acid
1
2004
12
0.060
 Why?
Telomerase
1
2004
26
0.060
 Why?
Carcinoma
1
2006
137
0.060
 Why?
Promoter Regions, Genetic
1
2007
465
0.060
 Why?
Polymorphism, Genetic
1
2005
180
0.060
 Why?
RNA Interference
2
2016
178
0.060
 Why?
RNA, Small Interfering
2
2016
208
0.060
 Why?
Tumor Burden
2
2016
130
0.060
 Why?
Cell Survival
2
2016
589
0.060
 Why?
Family Health
1
2004
77
0.050
 Why?
Genetic Counseling
1
2004
41
0.050
 Why?
Genomics
1
2004
279
0.050
 Why?
Epigenesis, Genetic
1
2006
372
0.050
 Why?
Researcher-Subject Relations
1
2002
1
0.050
 Why?
Ethical Review
1
2002
2
0.050
 Why?
Contract Services
1
2002
14
0.050
 Why?
Financial Support
1
2002
3
0.050
 Why?
Genetic Predisposition to Disease
1
2005
511
0.050
 Why?
Biotechnology
1
2002
13
0.050
 Why?
Cell Line
1
2004
988
0.050
 Why?
Health Care Sector
1
2002
15
0.050
 Why?
Mice, SCID
2
2012
178
0.050
 Why?
Drug Industry
1
2002
38
0.050
 Why?
Research Support as Topic
1
2002
45
0.050
 Why?
Research Subjects
1
2002
51
0.050
 Why?
Neoplasm Grading
1
2021
122
0.050
 Why?
Patient Selection
1
2002
259
0.040
 Why?
Cooperative Behavior
1
2002
225
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
12
0.040
 Why?
Cytoskeletal Proteins
1
2019
47
0.040
 Why?
Risk Assessment
1
2023
1270
0.040
 Why?
Microtubule-Associated Proteins
1
2019
66
0.040
 Why?
Biomedical Research
1
2002
244
0.040
 Why?
Cell Cycle Proteins
1
2019
161
0.040
 Why?
Cohort Studies
1
2021
1452
0.030
 Why?
Sensitivity and Specificity
1
2019
861
0.030
 Why?
Caspase 3
1
2016
93
0.030
 Why?
Retrospective Studies
2
2021
6263
0.030
 Why?
Tissue Array Analysis
1
2015
45
0.030
 Why?
Diagnosis, Differential
1
2019
1033
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2015
51
0.030
 Why?
Prospective Studies
1
2021
2378
0.030
 Why?
HEK293 Cells
1
2015
213
0.030
 Why?
Exosomes
1
2015
48
0.030
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2014
11
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
181
0.030
 Why?
Peritoneal Cavity
1
2014
8
0.030
 Why?
Risk Factors
2
2014
3724
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2014
181
0.030
 Why?
Drug Resistance, Neoplasm
1
2015
316
0.030
 Why?
Disease-Free Survival
1
2014
444
0.030
 Why?
MCF-7 Cells
1
2013
62
0.030
 Why?
Germ-Line Mutation
1
2013
61
0.030
 Why?
Homologous Recombination
1
2013
41
0.030
 Why?
Amino Acid Substitution
1
2013
81
0.030
 Why?
Karyotyping
1
2012
65
0.030
 Why?
Extracellular Matrix Proteins
1
2013
68
0.030
 Why?
Anoikis
1
2012
8
0.030
 Why?
Databases, Factual
1
2016
674
0.030
 Why?
Transduction, Genetic
1
2012
46
0.030
 Why?
Tubulin
1
2012
19
0.030
 Why?
Mice, Inbred NOD
1
2012
91
0.030
 Why?
Signal Transduction
2
2011
1624
0.030
 Why?
Tamoxifen
1
2012
60
0.030
 Why?
DNA Fingerprinting
1
2012
56
0.020
 Why?
Cell Adhesion
1
2012
157
0.020
 Why?
Antibody Specificity
1
2012
35
0.020
 Why?
Amino Acid Sequence
1
2013
574
0.020
 Why?
Perioperative Period
1
2011
22
0.020
 Why?
Tumor Suppressor Protein p53
1
2013
213
0.020
 Why?
Disease Models, Animal
1
2016
1436
0.020
 Why?
Estradiol
1
2012
221
0.020
 Why?
Microtubules
1
2011
36
0.020
 Why?
Cell Cycle Checkpoints
1
2011
29
0.020
 Why?
Gene Expression
1
2013
610
0.020
 Why?
Mitosis
1
2011
88
0.020
 Why?
Regression Analysis
1
2011
382
0.020
 Why?
HeLa Cells
1
2011
247
0.020
 Why?
Disease Progression
1
2012
829
0.020
 Why?
Cells, Cultured
1
2013
1571
0.020
 Why?
Severity of Illness Index
1
2011
978
0.020
 Why?
Progesterone Congeners
1
2008
5
0.020
 Why?
Progesterone
1
2008
57
0.020
 Why?
Mutation
1
2013
1281
0.020
 Why?
Protein Kinases
1
2008
71
0.020
 Why?
Cell Nucleus
1
2008
182
0.020
 Why?
Tumor Cells, Cultured
1
2008
457
0.020
 Why?
Transcriptional Activation
1
2006
119
0.020
 Why?
DNA, Neoplasm
1
2006
143
0.020
 Why?
Protein Structure, Tertiary
1
2006
245
0.020
 Why?
Binding Sites
1
2006
362
0.020
 Why?
Repressor Proteins
1
2006
148
0.010
 Why?
Pregnancy
1
2011
2451
0.010
 Why?
Truth Disclosure
1
2004
14
0.010
 Why?
Genetic Diseases, Inborn
1
2004
20
0.010
 Why?
Male
1
2011
25910
0.010
 Why?
Spillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (262) concept(s)
_
Similar People Expand Description
See all (39) people
_